A specific molecular signature in SARS-CoV-2 infected kidney biopsies
Abstract
Acute kidney injury (AKI) is one of the most important complications in COVID-19 patients and is considered a negative
prognostic factor with respect to patient survival. The occurrence of direct infection of the kidney by SARS-CoV-2, and its
contribution to the renal deterioration process, remains a controversial issue. By studying 32 renal biopsies from COVID-
19 patients we confirmed that the major pathological feature of COVID-19 is acute tubular injury (ATI). Using smFISH, we
showed that the SARS-CoV-2 infects living renal cells and that infection, which parallels renal ACE2 expression levels, is
associated to increase death. Mechanistically, a transcriptomic analysis uncovered specific molecular signatures in
SARS-CoV-2 infected kidneys as compared to healthy kidneys and non-COVID-19 ATI kidneys. On the other hand, we
demonstrated that SARS-CoV-2 and Hantavirus, two RNA viruses, activated different genetic networks despite they
triggered the same pathological lesions. Finally, we identified XAF1 as a critical target of SARS-CoV-2 infection. In
conclusion, this study demonstrates that SARS-CoV2 can directly infect living renal cells and identified specific druggable
molecular targets that can potentially aid in the design of novel therapeutic strategies to preserve renal function in
severely affected COVID-19 patients.
Domains
Life Sciences [q-bio]
Licence : CC BY - Attribution